-
喜讯丨XTL6001中选2026美国糖尿病协会科学年会(ADA) 减重与肾病两大适应症研究成果同时亮相
XTL6001 Selected for the 2026 American Diabetes Association (ADA) Scientific Sessions, with Dual Posters in Weight Management and Kidney Disease
넶2 2026-03-24 -
高效入组，里程碑达成！麦科奥特MT200605 II期临床研究完成全部360例受试者入组
Efficient Enrollment, Milestone Achieved! Micot’s MT200605 Phase II Clinical Study Completes Enrollment of All 360 Subjects
넶1 2026-03-24 -
MT1013-III-C01 临床研究中期研究者会圆满召开，聚焦中重度 SHPT 患者
MT1013-III-C01 Phase Ⅲ Clinical Study Midterm Investigator Meeting Successfully Concluded
넶1 2026-03-17 -
麦科奥特1类创新药注射用MT200605亨廷顿舞蹈病获美国FDA孤儿药资格认定
Micot's Class 1 Innovative Drug MT200605 Injection Receives Orphan Drug Designation from the U.S. FDA for Huntington's Disease
넶1 2026-03-17 -
擘画全球新蓝图：MT1013全球科学指导委员会2026年首次会议圆满召开
Charting a New Global Blueprint: Successful Inaugural 2026 Meeting of the MT1013 Global Scientific Steering Committee
넶0 2026-02-25
